Juntendo Co., Ltd., founded in 1951 and headquartered in Tokyo, Japan, operates primarily in the healthcare and pharmaceutical sectors. The company offers an extensive range of products and services including pharmaceutical manufacturing and sales; hospital and healthcare services; medical device production; clinical research and laboratory testing; and health and wellness support services. Juntendo serves both B2B clients such as hospitals and clinics, as well as end consumers primarily within Japan but with expanding regional operations.
In the last 1-2 years, Juntendo has focused on strategic expansion in healthcare services by forming partnerships with technology firms to enhance digital healthcare solutions and integrating advanced medical devices and AI diagnostics into their service offerings. There have been notable investments in clinical research capacities and launches of new pharmaceuticals aimed at chronic and lifestyle diseases. The company is also advancing its health management and wellness programs as part of a broader shift towards holistic healthcare provision.
Juntendo operates mainly in Japan but is increasing its footprint across Asia through alliances and joint ventures, supporting growth in pharmaceutical sales and medical services. The company maintains a strong research and development focus, underpinned by its foundation over 70 years ago. No recent name changes or major reorganizations have been reported.
Overall, Juntendo Co., Ltd. combines pharmaceutical manufacturing, hospital and healthcare operations, clinical research, medical device production, and health management services into a comprehensive healthcare corporation positioned for growth through innovation and strategic collaborations.